道彤投资
@author-1784793658606
以生命科学为根，向硬科技生长
Articles
Tonghuo | Vol. 06 Restoring Vision with Speed, Precision, and Accuracy — Eye Surgery Isn't Actually That Scary
**03:30** At different stages of life, we face different eye diseases.
Tonghuo | Vol.05 How Marvelous Are 3D-Printed Drugs? Maximum Precision with Minimum Dose
**03:43** Can You Split or Crush Pills? Don't Go Breaking Them Willy-Nilly
Tonghuo | Vol. 04: Don't Get Dazzled by Formulas — More Ingredients Don't Make a Better Supplement
**06:52** Targeted supplement intake before your reserves run dry
Tonghuo | Vol.03 Breeding Technology Is Evolving Seeds, and Food Is Entering an Era of Efficient Customization
**02:50** The core of breeding: combining the superior genes of each variety
Tonghuo | Vol.02 How Hearing Problems — "Sickness Entering Through the Ears" — Are Driving Us Apart from Our Parents
**03:10** What is hearing impairment? Who are the main groups affected by it?
Dalton Venture's Sun Qi: Seven Questions We're Pondering "In the Springtime" | Dalton Insights
What should investors do to keep up with the changes of this era?
Tonghuo｜Vol.01 Anaerobic Bio's Cheng Lei: Microbes That Reach for the Sky and Burrow Into the Earth — Mastering Fermentation, Preservation, and Pharmaceuticals
**The life-science and biotechnology revolution unfolding in the world right now — it actually has something to do with you, too.**
Life sciences isn't as distant as you think — come chat with us and you'll see | Dalton Venture has its own podcast now
Let me tell you stories about life sciences.
Spring in Full Bloom, Brilliance Across All Things | Dalton Venture's 2024 CEO Summit Successfully Held
The annual Two Sessions have always been a critical barometer for China's economic trajectory and policy direction. This March, when the government elevated "new quality productive forces" to the top of its work agenda, it sparked intense interest and vigorous debate across industries about this buzzword. As one of the most dynamic drivers of technological innovation and industrial transformation—and a strategic emerging industry that lies at the heart of future industrial planning—how should the medical sector translate new quality productive forces into practice? And where will it steer the development and transformation of the life sciences industry?
VBData Exclusive | Dalton Venture: The Next Phase of Opportunities in Healthcare — "Technology + Safety" Is the Unavoidable Theme
In a turbulent environment, most investment firms have chosen to play it safe, pulling back on deal activity. Yet in 2023 — widely called a funding winter — Dalton Venture actually picked up its investment pace. How does the firm see 2024 shaping up? At the start of the new year, Sun Qi, founding and managing partner of Dalton Venture, sat down with VBData to share his outlook on healthcare trends for 2024 and his advice for founders.